Irvine Oral & Maxillofacial is categorized under Surgeons in Irvine, CA and active since 2011.
Irvine Oral & Maxillofacial was established in 2011, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Surgeons business, which does work in the B2C market, and is classified as a Surgeons, under code number 6212100 by the NAICS.
If you are seeking more information, feel free to contact Jeffrey Elo, Principal at the company’s single location by writing to 4950 Barranca Parkway # 202, Irvine, California CA 92604 or by phoning (714) 556-7000. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Irvine Oral & Maxillofacial |
| Contact Person: | Jeffrey Elo, Principal |
| Address: | 4950 Barranca Parkway # 202, Irvine, California 92604 |
| Phone Number: | (714) 556-7000 |
| Website Address: | irvineoms.com |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2011 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Surgeons |
| SIC Code: | 8011 |
| NAICS Code: | 6212100 |
| Share This Business: |
Irvine Oral & Maxillofacial was started in 2011 to provide professional Surgeons under the SIC code 8011 and NAICS code 6212100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Jeffrey Elo, Principal for inquiries that concern Irvine Oral & Maxillofacial by calling the company number (714) 556-7000, as your correspondence is most welcome. Additionally, the physical location of the single location of Irvine Oral & Maxillofacial can be found at the coordinates 33.676228,-117.794775 as well as the street address 4950 Barranca Parkway # 202 in Irvine, California 92604.
For its online presence, you may visit Irvine Oral & Maxillofacial’s website at irvineoms.com and engage with its social media outlets through on Twitter and on Facebook.